IBRX - ImmunityBio Inc
IEX Last Trade
3.96
0.160 4.040%
Share volume: 2,275,939
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.80
0.16
4.21%
Summary score
26%
Profitability
22%
Dept financing
25%
Liquidity
49%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
22.39%
Return on assets
-24.87%
Return on sales
-262683.26%
Return on invested capital
-53.19%
Total debt ratio
179.23%
Debt ratio change over timeo
-0.49%
Current Ratio
2.14%
Quick Ratio
2.14%
Cash Position Ratio
1.91%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
25.96%
Return on assets
-22.48%
Return on sales
-153840.7%
Return on invested capital
-70.49%
Total debt ratio
251.19%
Debt ratio change over timeo
-5.1%
Current Ratio
2.79%
Quick Ratio
2.79%
Cash Position Ratio
2.48%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
19.38%
Return on assets
-23.76%
Return on sales
-237990%
Return on invested capital
-88.7%
Total debt ratio
272.71%
Debt ratio change over time
-2.78%
Current Ratio
3.64%
Quick Ratio
3.64%
Cash Position Ratio
3.17%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-82.95%
Return on assets
-107.33%
Return on sales
310130.71%
Return on invested capital
-77.74%
Total debt ratio
-48.6%
Debt ratio change over time
-0.49%
Current Ratio
-2.79%
Quick Ratio
-2.79%
Cash Position Ratio
-2.72%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IBRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 22.39% | 13.79% | 34.47% | 7.43% |
| Return on assets | -24.87% | 2.76% | 3.15% | 5.62% |
| Return on sales | -262683.26% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -53.19% | 2.36% | 5.39% | 19.77% |
| Profitability | 16% | 43% | 66% | 80% |
| Total debt ratio | 179.23% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.49% | 308.97% | -6.99% | 1.18% |
| Dept financing | 25% | 38% | 13% | 4% |
| Current Ratio | 2.79% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.79% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.48% | 0.36% | 1.28% | 2.93% |
| Liquididy | 50% | 14% | 33% | 75% |
| Short-term ratios | IBRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 25.96% | 13.77% | 13.25% | 3.8% |
| Return on assets | -22.48% | 2.43% | 1.89% | 3.09% |
| Return on sales | -153840.7% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -70.49% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 59% | 57% | 79% |
| Total debt ratio | 251.19% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -5.1% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 34% | 9% | 3% |
| Current Ratio | 2.79% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.79% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.48% | 0.36% | 1.28% | 2.93% |
| Liquididy | 49% | 12% | 31% | 75% |